OS Therapies Inc
ostherapies.comAI Executive Summary
AI-powered analysis of 10-Q filing content
OS Therapies shows severe financial deterioration with net losses increasing 168% year-over-year to $10.4M in Q1 2026. The company is technically insolvent with stockholders' deficit expanding to -$10.8M and current liabilities of $17M far exceeding cash of $918K, creating immediate liquidity concerns.
Red Flags Detected (7)
Stockholders' deficit increased 78% from -$6.1M to -$10.8M in one quarter
Current liabilities of $17M vs only $918K cash - severe liquidity crisis
Net loss increased 168% year-over-year from $3.9M to $10.4M
4 more red flags detected
Key Takeaways
Company faces immediate bankruptcy risk with current liabilities 18x exceeding cash
Massive R&D spending increase suggests late-stage clinical trials but with extreme financial risk
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.